WA-TANIUM
6.1.2022 21:41:12 CET | Business Wire | Press release
Industry experts are naming Log4j one of the most severe internet and computer vulnerabilities they have encountered. The United States Cyber Security and Infrastructure Security Agency (CISA) Director stated that the Log4j vulnerability: “…is one of the most serious I’ve seen in my entire career, if not the most serious.”
Log4j is the perfect storm of severity, pervasiveness, and ease of exploitability. It is an open-source code library widely used inside commercial and open-source software applications. The recently discovered vulnerability allows hackers to take complete control of affected endpoints with a single line of code. As a result, finding and fixing every single instance of Log4j and applications that rely on it is critical for corporate networks.
The key to finding all instances of Log4j is the ability to look inside every file in a corporate network and Tanium is the only solution that, in minutes, can look inside every file, and find every instance of Log4j, at scale today.
Tanium is supporting organizations globally in the eradication of Log4j vulnerabilities. The Tanium Platform uniquely enables organizations to manage their exposure by:
- Looking inside nested archive folders and files for vulnerabilities
- Finding references to Log4j even if they were renamed (maliciously or by design)
- Automating software upgrades and patches at scale to all vulnerable systems
- Watching, alerting, and remediating any new instance of the vulnerability that is inadvertently introduced post-cleanup
Ring Power Corp. was able to scan every file and folder and find every single instance of Log4j with their entire environment in only minutes. “Tanium Reveal has been critical to us in responding to Log4j. Nobody else was able to search for references to the impacted library in common file formats and detect instances of exploitation. With Tanium, we accomplished in 30 minutes what would have taken months.” - Kevin Bush, VP of IT at Ring Power Corp.
Salisbury University stated “We saw first-hand the strength of Tanium during the Log4j vulnerability crisis. Tanium made us aware of many endpoints that were vulnerable to Log4j through user-installed tools and applications that we weren’t aware of.” – Steven Blankenship, Director of IT
To set up a Tanium evaluation of your environment for the Log4j vulnerability, please contact us at https://www.tanium.com/log4j/ .
About Tanium
Tanium is the platform that the most demanding and complex organizations trust to gain visibility and control across all endpoints in on-premises, cloud and hybrid environments. Tanium addresses today’s increasing IT challenges with high fidelity endpoint data — giving IT operations, security and risk teams confidence to quickly manage, secure and protect their networks at scale. Nearly half of the Fortune 100, top retailers and financial institutions, and multiple branches of the U.S. Armed Forces trust Tanium to help see and control every endpoint, everywhere. That’s the power of certainty. Tanium has been named to the Forbes Cloud 100 list of “Top 100 Private Companies in Cloud Computing” for six consecutive years and ranks on FORTUNE’s list of the “Best Large Workplaces in Technology 2021.” Visit www.tanium.com and follow us on LinkedIn and Twitter .
View source version on businesswire.com: https://www.businesswire.com/news/home/20220106005859/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces the European Commission Approval of Zynyz® (retifanlimab) for the First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC)6.3.2026 22:42:00 CET | Press release
- Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) is the first systemic treatment for adult patients with advanced SCAC in Europe- The EC approval is based on results of the POD1UM-303 study which showed that adult patients with advanced SCAC achieved significantly improved progression-free survival with Zynyz in combination with carboplatin and paclitaxel as a first-line treatment compared to chemotherapy alone.1 Incyte (Nasdaq:INCY) today announced that the European Commission (EC) has approved Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) for the first-line treatment of adult patients with metastatic or with inoperable locally recurrent squamous cell carcinoma of the anal canal (SCAC). “The EC approval of Zynyz marks an important step forward for patients with advanced SCAC, a rare cancer for which meaningful treatment advances have not occurred in several decades,” said Bill Meur
Dfns Launches Payouts6.3.2026 21:27:00 CET | Press release
Dfns today announced the launch of Payouts, a new API enabling institutions to convert stablecoins to fiat and route payouts across multiple bank accounts while keeping wallet-level governance and controls in place. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260305327930/en/ Convert stablecoins to fiat and settle payouts to bank accounts in 94 countries, today. Solving the problem of single-rail off-ramps Today, most fintechs and institutions still hard-wire a single payout provider into their stack, or rely on vertically integrated models that bundle routing, pricing, custody, and settlement together. That approach may be convenient early on, but it creates structural problems at scale: weak price discovery because there is no competitive pressure on margins, limited auditability because routing decisions are opaque, and operational fragility because a single provider degradation in any corridor requires architectural i
Klarna Group Plc Clarifies Mechanics of March 9 Lock-Up Expiration6.3.2026 20:23:00 CET | Press release
Klarna Group plc (NYSE: KLAR) today issues the following clarification to ensure investors and market participants have accurate information regarding the mechanics of its lock-up expiration on March 9, 2026, the processes required before pre-IPO shares can be traded on the NYSE, and the prior liquidity opportunities already available to shareholders. This release contains only factual descriptions of the Company's share structure and applicable processes. It does not constitute guidance or a projection of any kind regarding future trading volumes, share price, or the intentions of any shareholder and speaks only as of the date of this press release. 1. 335 million locked-up shares — but two different categories Of the 378 million total ordinary shares outstanding, approximately 335 million are subject to lock-up restrictions expiring March 9, 2026. However, these shares fall into two distinct categories governed by separate sets of regulations. A. 159 million shares (48% of locked-up
Lone Star Funds Announces Agreement to Acquire the Capsules & Health Ingredients Division of Lonza Group AG6.3.2026 18:30:00 CET | Press release
Lone Star Funds (“Lone Star”) today announced that an affiliate of Lone Star Fund XII, L.P. has entered into a definitive agreement to acquire the Capsules & Health Ingredients (“CHI”) division of Lonza Group AG. As part of the transaction, Lonza will retain a 40% equity position in the business. Headquartered in Basel, Switzerland, CHI operates globally across the Americas, Europe and Asia Pacific. The business comprises three segments: Hard Empty Capsules: leading global manufacturer of gelatin and plant-based capsules offering a broad range of innovative solutions for pharmaceutical and nutraceutical customers. Dosage Form Solutions: end-to-end development and manufacturing platform serving nutraceutical and pharmaceutical customers. Health Ingredients: provider of branded, science-backed nutrition ingredients serving joint health, energy and active lifestyle markets. Lone Star believes CHI is a high-quality, globally recognized platform with strong technical capabilities, different
Sutherland Launches FinAI Hub to Industrialize Agentic AI for Banking and Financial Services6.3.2026 14:00:00 CET | Press release
A domain-trained AI agent workforce enables production-scale AI across regulated financial institution operations Today, Sutherland announced the launch of Sutherland FinAI Hub, an enterprise Agentic AI platform built exclusively for Banking and Financial Services. As financial institutions accelerate AI adoption, many initiatives remain confined to pilots, unable to scale across legacy systems and core operations. Sutherland FinAI Hub is designed to help close that gap. FinAI Hub is an innovation ecosystem where Sutherland works with clients to design, prototype, and scale Agentic AI workflows across core operations. At launch, the platform brings together a large and expanding workforce of domain-trained AI agents purpose-built for financial institutions, supporting functions across retail banking, payments, cards, consumer and commercial lending, servicing, back office, risk and compliance functions. These modular agents can operate independently or be orchestrated across end-to-end
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
